[Chlormethiazole in the treatment of complex partial epileptic status in childhood]
Insights
Chlormethiazole successfully controlled complex partial status epilepticus (CPSE) in a pediatric patient when other anticonvulsants failed. Early use of chlormethiazole may prevent cognitive deficits associated with prolonged seizures.
Area of Science:
- Neurology
- Pediatric Neurology
- Clinical Neurophysiology
Background:
- Complex partial status epilepticus (CPSE) is a prolonged seizure state requiring effective management.
- Refractory CPSE poses significant treatment challenges, particularly in pediatric cases.
- Standard anticonvulsant therapies may not always be sufficient for CPSE control.
Observation:
- A 9-year-old boy presented with CPSE following initial partial secondary generalized epileptic seizures.
- Electroencephalography revealed diffuse delta dysfunction and bilateral epileptiform activity.
- Initial treatment with diazepam, phenytoin, and phenobarbitone was ineffective in terminating the CPSE.
Findings:
- Continuous intravenous chlormethiazole infusion successfully controlled the CPSE, indicated by the disappearance of paroxysmal discharges and reduced slow-wave activity.
- The patient experienced transient memory deficits, nominal dysphasia, and tactile dysgnosia post-seizure, correlating with EEG findings.
- Subsequent oral administration of chlormethiazole and phenytoin led to near-normal cognitive function with no reported side effects.
Implications:
- Chlormethiazole is a potentially valuable therapeutic agent for managing refractory CPSE, especially in children.
- Earlier consideration of chlormethiazole could mitigate severe cognitive sequelae often seen in prolonged status epilepticus.
- This case highlights the efficacy of chlormethiazole and suggests its broader use to avoid last-resort treatments like barbiturate anesthesia.
Abstract:
The authors report on the results of clinical investigations, treatment and follow-up of a 9-year old boy with complex partial status epilepticus (CPSE) which occurred after the first onset of partial secondary generalized epileptic seizures. Electroencephalografic recordings during status epilepticus showed a diffuse, generalized, high-voltage delta dysfunction and bilateral epileptiform activity, with local maximum over the posterior right temporal parietal regions. Parenteral administration of diazepam, phenytoin and phenobarbitone as choice anticonvulsant drugs, failed to stop CPSE in the patient. Only by continuous intravenous infusion of chlormethiazole (Heminevrin) status epilepticus was successfully controlled. Paroxysmal discharges on electroencephalogram disappeared and attenuation of slow wave activity was evident. Memory deficits and the elements of nominal dysphasia and tactile dysgnosia were apparent soon after cessation of CPSE and may be related to the signs of maximal local electroencephalographic dysfunction. Later testings after complete seizure control by chlormethiazole and phenytoin given orally, showed almost normal results. No side effects were encountered. A more common chlormethiazole administration as a useful therapeutic agent in the management of CPSE especially in children with refractory and long-time status, would be mandatory. Since chlormethiazole is free from serious side effects, its earlier use in the control of epileptic status may help to preclude some severe cognitive effects and to evade the use of barbiturate anesthesia as the last therapeutic resort.
More Related Videos
09:57Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
06:04Frontal Disconnection for Treating Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE) in the Frontal Lobe
Published on: August 16, 2024
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Epilepsy ll: Types
